AbCellera Biologics (ABCL) Interest & Investment Income: 2019-2024
Historic Interest & Investment Income for AbCellera Biologics (ABCL) over the last 6 years, with Dec 2024 value amounting to $38.5 million.
- AbCellera Biologics' Interest & Investment Income rose 29.50% to $11.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $42.2 million, marking a year-over-year increase of 162.32%. This contributed to the annual value of $38.5 million for FY2024, which is 8.93% down from last year.
- Per AbCellera Biologics' latest filing, its Interest & Investment Income stood at $38.5 million for FY2024, which was down 8.93% from $42.2 million recorded in FY2023.
- AbCellera Biologics' 5-year Interest & Investment Income high stood at $42.2 million for FY2023, and its period low was $293,000 during FY2020.
- Over the past 3 years, AbCellera Biologics' median Interest & Investment Income value was $38.5 million (recorded in 2024), while the average stood at $32.3 million.
- As far as peak fluctuations go, AbCellera Biologics' Interest & Investment Income soared by 1,036.52% in 2021, and later decreased by 8.93% in 2024.
- Yearly analysis of 5 years shows AbCellera Biologics' Interest & Investment Income stood at $293,000 in 2020, then skyrocketed by 1,036.52% to $3.3 million in 2021, then surged by 382.85% to $16.1 million in 2022, then spiked by 162.75% to $42.2 million in 2023, then decreased by 8.93% to $38.5 million in 2024.